Varicose Vein Disease Clinical Trial
Official title:
FOAM-study Cost Minimization Study Comparing Surgery Versus Duplex Guided Foam Sclerotherapy of Varicose Veins: a Randomized Controlled Study
Varicose vein disease is a common health problem, which causes much discomfort to patients.
Nowadays treatment modalities for greater saphenous veins include surgery and duplex guided
foam sclerotherapy. These are two equally accepted and applied treatments for the same
patient population.
Choice of treatment often depends on the referral preference of the General Practitioner.
Until now data are missing which treatment is more cost effective. The current proposal aims
at comparing the effects, costs and patient preferences between duplex guided foam
sclerotherapy and surgery in the treatment of greater varicose veins.
Status | Completed |
Enrollment | 460 |
Est. completion date | January 2010 |
Est. primary completion date | December 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - incompetence of great saphenous vein for minimal 20 cm - life expectancy at least 3 years - open and competent deep venous system - willing to undergo both treatments Exclusion Criteria: - active ulcer - signs of deep venous thrombosis with duplex - incompetence of the deep venous system |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Netherlands | Maastricht UMC | Maastricht |
Lead Sponsor | Collaborator |
---|---|
Maastricht University Medical Center | ZonMw: The Netherlands Organisation for Health Research and Development |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | cumulative probability of recurrent varicose vein within 24 months after treatment | 24 months | No | |
Secondary | quality of life (as measured by EuroQol-5D) | 24 months | No | |
Secondary | patient preferences (as measured by conjoint analysis) | 24 months | No | |
Secondary | direct Health care costs | materials, operation costs, personnel costs | 24 months | No |